Dissecting the genetic architecture of lipids, lipoproteins and apolipoproteins, Lessons from twin studies by Snieder, H. et al.
ISSN: 1524-4636 
Copyright © 1999 American Heart Association. All rights reserved. Print ISSN: 1079-5642. Online
7272 Greenville Avenue, Dallas, TX 72514
Arteriosclerosis, Thrombosis, and Vascular Biology is published by the American Heart Association.
 1999;19;2826-2834 Arterioscler Thromb Vasc Biol
Harold Snieder, Lorenz J. P. van Doornen and Dorret I. Boomsma 
 : Lessons From Twin Studies
Dissecting the Genetic Architecture of Lipids, Lipoproteins, and Apolipoproteins
 http://atvb.ahajournals.org/cgi/content/full/19/12/2826
located on the World Wide Web at: 
The online version of this article, along with updated information and services, is
 http://www.lww.com/reprints
Reprints: Information about reprints can be found online at 
  
 journalpermissions@lww.com
410-528-8550. E-mail: 
Fax:Kluwer Health, 351 West Camden Street, Baltimore, MD 21202-2436. Phone: 410-528-4050. 
Permissions: Permissions & Rights Desk, Lippincott Williams & Wilkins, a division of Wolters
  
 http://atvb.ahajournals.org/subscriptions/
Biology is online at 
Subscriptions: Information about subscribing to Arteriosclerosis, Thrombosis, and Vascular
 at Vrije on December 23, 2010 atvb.ahajournals.orgDownloaded from 
Dissecting the Genetic Architecture of Lipids,
Lipoproteins, and Apolipoproteins
Lessons From Twin Studies
Harold Snieder, Lorenz J.P. van Doornen, Dorret I. Boomsma
Abstract—We review the ways in which twin studies have been used to investigate the genetic architecture of lipids,
lipoproteins, and apolipoproteins. We focus on the age dependency of genetic effects and the importance of pleiotropy
for the lipid system. Finally, consequences are discussed of age dependency and pleiotropy for the design and power
of twin studies aimed at detecting the actual quantitative trait loci (QTLs) involved. It is concluded that twin studies have
played an important role and will remain highly valuable for the elucidation of the genetic architecture of lipids,
lipoproteins, and apolipoproteins. Twins can efficiently be used to identify the location and function of QTLs. Taking
account of pleiotropy and age-dependent gene expression in study design and data analysis will improve the power and
efficiency to find these QTLs for components of the lipid system. (Arterioscler Thromb Vasc Biol.
1999;19:2826-2834.)
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The heritability of a specific trait or disease, defined as theproportion of variance determined by genetic factors, has
traditionally been the main outcome parameter of the classic
twin study. For most lipids and (apo)lipoproteins, for exam-
ple, large heritabilities have been shown, providing a com-
pelling argument to start the search for their genes. For
several reasons, twin studies have recently moved away from
merely calculating heritabilities based on measurements of
single traits at single time points. First, heritabilities derived
from cross-sectional studies are merely “snapshots” of a
specific point in time: they do not give information on the
underlying genetic and environmental sources of continuity
and change in the development of the disease or disease trait.1
Second, many traits or risk factors for disease show a certain
degree of interrelatedness, which may be due to the pleiotro-
pic action of genes and/or common environmental influences.
Extensions of the classic twin study to more complex designs
involving multiple time points and multiple variables are
needed to shed light on these questions.
Recent progress in molecular genetics and accompanying
developments in biostatistics mark a new era in genetics in
which the mapping of quantitative trait loci (QTLs) underly-
ing complex nonmendelian traits and diseases has become
within reach. In this new molecular-genetic era, twin studies
remain highly valuable and can efficiently be used to identify
the location and function of QTLs underlying, for example,
complex lipid traits.2
This review has 2 main aims. The first is to describe the
ways in which twin studies have been used to investigate the
genetic architecture of lipids, lipoproteins, and apolipopro-
teins. More specifically, we discuss the age dependency of
genetic effects and the importance of the concept of pleiot-
ropy (ie, the same gene or set of genes simultaneously
influences multiple traits) for the lipid system. Second, we
discuss the consequences of age dependency and pleiotropy
for twin studies aimed at detecting the actual genes involved.
Developmental Trends
Trends in Means
Lipids, including cholesterol and triglycerides, are trans-
ported in the circulation by a number of different lipoproteins,
of which VLDL, LDL, and HDL are the most important.
Apolipoproteins are bound to the surface of the lipoprotein
particles and play an important role in lipid metabolism:
through apolipoproteins, lipoproteins are actively recognized,
bound, and absorbed by specific receptors.3 Apolipoprotein
A1 (apoA1) is part of HDL, and apolipoprotein B (apoB) is
the sole protein of LDL. Another particle of the lipid system,
lipoprotein(a) [Lp(a)], was first described by Berg4 and is
structurally related to LDL.5 All of these constituents of the
lipid sytem are important risk factors for coronary heart
disease, as established by numerous epidemiological
studies.6–9
The most dramatic changes in lipids, lipoproteins, and
Lp(a) occur during the first years of life. During the first 6
months, concentrations double or triple.10,11 Lp(a) concentra-
tions already reach adult levels at 8.5 months.11 Levels of
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other lipid traits rise further at a slower rate until about 2 to
3 years, when they approach young-adult levels. Cholesterol
and HDL increase slightly between 3 and 5 years. No clear
sex differences exist yet.12 In preadolescents (5 to 10 years),
cholesterol and triglyceride levels remain fairly constant.13
During puberty (12 to 16 years), cholesterol declines by
10% to 20% in boys, after which time it starts to rise, reaching
preadolescent levels again by 20 years of age. In girls the
picture is less clear: a drop is sometimes reported,14 but a
recent longitudinal study observed no change.15 HDL levels
in boys descend in this period but remain unchanged in
girls.14,15 Triglyceride levels show an increase in both sexes
during adolescence, but the relative increase is higher in boys
than in girls.14 By the end of puberty, girls have equal
cholesterol and triglyceride levels but higher HDL levels than
do boys. The apoA1 and apoB changes during puberty
parallel those in HDL and total cholesterol, respectively.
Lp(a) shows no changes during this period and does not differ
between sexes.16,17
The development in young males, between 18 and 30
years, shows an increase of cholesterol, LDL, triglycerides,
and apoB and no change in HDL. In women, little change18 or
a rise is observed for cholesterol and LDL,15 a decline in
triglycerides, and a rise in HDL and apoA1.18 This results in
the typical sex difference in lipid profile as observed in the
middle-aged population. Up to 50 years of age, cholesterol,
LDL, and triglycerides continue to rise and HDL decreases
slightly in both sexes.19 In this period, males have higher
cholesterol, triglyceride, LDL, and apoB levels but lower
HDL and apoA1 levels than do females.20,21 After the age of
50, female cholesterol levels exceed male levels.20 Lp(a)
increases slightly between 20 and 59 years and has the same
level in both sexes in all age groups.22
Some lipids are influenced by the menopause. Matthews et
al23 performed a follow-up study of premenopausal women.
In some women, menopause occurred during the follow-up
period. Menopause led to a significant decrease in HDL. The
increase in LDL was twice as large in menopausal compared
with premenopausal women of the same age during follow-
up. Total cholesterol, triglycerides, apoA1, and apoB changed
to the same extent in both groups. Thus, apart from an age
effect, no specific influence of menopause on these variables
was evident. Lp(a) levels are a bit higher in postmenopausal
women, but the effect disappears after age correction.22
In elderly people, from '65 years on, cholesterol levels
drop, especially in males. HDL remains stable.24,25 The fall in
total cholesterol with old age, however, may represent cohort,
period, or survivorship effects or a combination of these
effects, rather than a true decline.26
To summarize, plasma lipid and (apo)lipoprotein levels
vary considerably with age; the changes of the different lipid
components do not run in parallel, and they differ for males
and females. Superimposed on the global change during the
whole life span, 4 more specific periods are associated with
more dramatic changes: the first years after birth, adoles-
cence, the menopausal period in females, and old age. These
(sex-specific) age trends in lipid and (apo)lipoprotein levels
indicate that different genetic and/or environmental factors
may be involved in males and females and at different ages.
Trends in Variances
Generation and sex influences on the variances of compo-
nents of the lipid system are less well understood than mean
trends. Most studies did not have an explicit interest in age
and sex trends in variances. Nevertheless, the large popula-
tion studies on age and sex trends in mean levels also provide
standard deviations. From these, it can be deduced that
variances increase in most lipids and (apo)lipoproteins be-
tween early adulthood (between 20 and 29 years of age) and
middle age (between 40 and 59 years of age) in both males
and females.19,20 During middle age, variances in lipids and
(apo)lipoproteins remain relatively stable.19,20,25,27 Only in
old age (701) are there indications for a decline.20 These
results pertain to both sexes. Except for the drop during old
age, variance trends in Lp(a) are similar.22
In contrast to the above-mentioned studies, Reilly et al28
specifically investigated the effects of sex and generation on
variances in lipids and (apo)lipoproteins. Lipid variances
were compared between grandparents (mean age 68), parents
(mean age 42), and children (mean age 15) of both sexes.
Significant differences between generations were found for
total cholesterol and LDL in both males and females and for
triglycerides, HDL, and apoA1 in males only. Differences
could be explained by an increase in variance with age.
Similar results were found by Boomsma et al29 in a study of
160 adolescent twin pairs and their parents. Variances were
significantly higher in the parental generation for total cho-
lesterol, triglycerides, HDL, LDL, apoA1, and apoB. Only
Lp(a) did not show a generation effect.
In summary, most studies report an increase in variance
with age for most lipid traits in both sexes. Such an increase
in lipid and (apo)lipoprotein variance from adolescence to
adulthood may be due to interindividual variation in the rise
of lipid levels over time and can only be explained by an
increase in 1 or more of the underlying variance components,
which can be either genetic or environmental.
Genetic Developmental Trends
Genetic factors have been shown to exert considerable
influence on levels of lipids, lipoproteins, and apolipopro-
teins. A large number of monogenic disorders have been
described,30 but they can account for only a relatively small
portion of the population variance in lipid concentrations.
Quantitative genetic studies of twins and families indicate
that a considerable part of the variation in lipids, lipoproteins,
and apolipoproteins results from as-yet-unknown polygenic
influences (reviewed in References 31 through 37).
As stated, sex-specific age trends in the levels and vari-
ances of lipid traits may indicate that different genetic and
environmental factors may be influential in different sex-age
cohorts. This age dependency can take 2 different forms.
First, the magnitude of the genetic influence (ie, the herita-
bility) of the lipid trait can differ with age. Second, different
genes may affect the trait at different ages; ie, the expression
of genes may depend on age. To investigate these 2 possibil-
ities we (1) review evidence from cross-sectional studies of
twins in different age ranges, (2) compare correlations be-
tween familial pairings that differ in their intrapair age
difference: parent-offspring versus sib-pairs versus dizygotic
(DZ) twin pairs, and (3) discuss the limited number of (quasi)
longitudinal twin studies.
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Twin Studies
When twins within a specific age range are measured in
studies estimating the genetic influence on lipids, lipopro-
teins, and apolipoproteins, heritabilities for this specific age
range are obtained. To obtain an impression of possible age
trends in heritability, we have listed recent twin studies (since
1977) in ascending order according to the age of the twin
sample. Twin studies before 1977 were reviewed by Iselius.31
Estimates for males and females are given separately. Heri-
tability, estimated as 2(rMZ2rDZ),38 was listed for all studies
that did not use model-fitting techniques. Some components
of the lipid system that have been shown to be heritable and
may confer a risk for coronary heart disease, such as LDL
subclass phenotypes34,101 and apoAII and apoE levels,29 were
not included in the Tables, as they were measured in only 1
or 2 twin studies. Results for lipids and lipoproteins are
shown in Table 1. Although these studies used different
methods to estimate heritability, results were relatively con-
sistent. Most studies found that in both males and females,
.50% of the total variance in total cholesterol, LDL, HDL,
and triglycerides could be explained by genetic factors.
Furthermore, the studies listed did not find much support for
a considerable influence of the shared-family environment.
No obvious age trend in heritability estimates can be detected
from Table 1. Heritabilities measured before39 and during29
puberty are highly similar, and they remain fairly constant
during early adulthood and middle age. Only in the elderly do
heritabilities seem to decrease.35
Table 2 shows the results for apolipoproteins and Lp(a).
Because fewer studies with mostly smaller twin samples were
done for apolipoproteins, estimates were somewhat more
variable compared with those in Table 1. Observed heritabil-
ities were roughly within the same range as for lipids and
lipoproteins. High heritabilities for Lp(a) are in accordance
with findings that the apo(a) gene accounts for .90% of the
variation in Lp(a) concentration.48,49 Again, a clear age trend
cannot be detected, although Heller et al35 found a signifi-
cantly smaller heritability for apoB in their older compared
with their younger twin sample.
Comparison of Different Familial Correlations
Another approach to investigate the age dependency of
genetic and environmental effects is to compare correlations
between familial pairings that differ in their intrapair age
difference.56 An age-dependent genetic or environmental
effect would predict an increase in the familial correlation
with decreasing age difference: r(parent-offspring) , r(sib-
pair) , r(DZ). Such a pattern was confirmed for cholesterol,
as shown in a review by Iselius31 of earlier twin and family
studies. For 4716 parent-offspring pairs, a mean correlation
of 0.26 was found, whereas for 2056 sibling pairs and 622
pairs of DZ twins, these values were 0.34 and 0.44, respec-
tively. An alternative explanation for the lower parent-
offspring correlation compared with the sibling or DZ twin
correlation could be the influence of genetic dominance. This,
however, cannot explain the difference between the sibling
TABLE 1. Twin Studies Estimating Heritability (h 2) in Lipids and Lipoproteins, in Ascending Order According to Age
Investigator Pairs of Twins
Age, y
Sex Adjustment
h 2
Mean (SD) Range TC LDL HDL TRG
Bodurtha et al39 65 MZM, 68 MZF 11.0 (?) ? Male 0.71 0.85 0.76 0.68
23 DZM, 27 DZF, 50 DOS Female 0.80 0.85 0.76 0.68
Boomsma et al29 35 MZM, 35 MZF 16.7 (2.0) 13.0–22.0 Male 0.80 0.82 0.71 0.60
31 DZM, 30 DZF, 29 DOS Female 0.80 0.82 0.71 0.60
Whitfield and Martin40 42 MZM, 42 MZF 23.1 (4.6) 18.0–34.0 Male 0.54 0.24 0.53
38 DZM, 44 DZF, 39 DOS Female 0.54 0.24 0.51
Knoblauch et al41 100 MZ, 72 DZ 33.0 (14.0) 15.0–69.0 Sex 0.58 0.59 0.61 0.66
Hunt et al42 73 MZM, 81 DZM 34.5 (9.5) 21.0–61.0 Age 0.61 0.74 0.81
Age, env 0.65 0.51 0.75
O’Connell et al33 39 MZM, 67 MZF 36.3 (12.4) 17.0–66.0 Sex 0.58 0.89 0.60
25 DZM, 69 DZF Sex, env 0.79 1.00 0.63
Williams et al43 44 MZF, 31 DZF 37.6 (?) 17.0–64.0 0.64 0.67 0.71
Austin et al44 233 MZF, 170 DZF 42.0 (?) ? Age 0.98 0.68 0.80
Age, env 0.92 0.82 0.63
Berg45 35 MZM, 43 MZF ? (?) 33.0–61.0 Male 0.40 0.00
33 DZM, 47 DZF Female 0.40 0.72
Snieder et al46 39 MZM, 50 MZF 44.1 (6.7) 34.0–63.0 Male 0.68 0.69 0.71 0.59
36 DZM, 40 DZF, 38 DOS Female 0.68 0.69 0.71 0.59
Kervinen et al100 16 MZA 45.6 (11.8) ? 0.33 0.30 0.73 0.73
Age, sex, wt, ht 0.28 0.22 0.59 0.32
Feinleib et al47 250 MZM, 264 DZM 48.0 (?) 42.0–56.0 0.43 0.57 0.46 0.56
Heller et al35 57 MZ, 94 DZ ? (?) 52.0–65.0 Age, sex 0.63 0.76 0.72
56 MZ, 95 DZ ? (?) 66.0–86.0 Age, sex 0.32 0.55 0.28
TC indicates total cholesterol; TRG, triglyceride; MZM, monozygotic males; MZF, monozygotic females; DZM, dizygotic males; DZF, dizygotic females; DOS, dizygotic
opposite sex; env, environment; and MZA, monozygotic twins reared apart.
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and DZ twin correlation. In accordance with Iselius,31
Boomsma et al29 also observed lower parent-offspring than
DZ twin correlations for lipids, lipoproteins, and apolipopro-
teins. Two types of age effect could offer an explanation for
the decrease in familial correlation with increasing intrapair
age difference. First, the influence of nonshared environmen-
tal factors could increase with age. However, such an effect
would mean an accompanying decrease of heritability with
age, which is incompatible with the results listed in Tables 1
and 2. A more likely explanation, therefore, is that the
expression of genes may vary with age (eg, genes may switch
on and off during development), while the magnitude of
heritability remains relatively stable. Recent studies on body
mass index57 and blood pressure58–60 indicate that it may well
be possible that the same phenotype is influenced by different
genes in different periods of life. This assumption has been
tested in a limited number of longitudinal twin studies.
Longitudinal Studies
Nance et al61 investigated the causes for continuity and
change of HDL cholesterol during adolescence. Longitudinal
data of monozygotic (MZ) and DZ twins at 11, 12.5, and 14
years of age were analyzed by multivariate model–fitting
techniques. The magnitude of the random environmental
influence was constant over time and specific for each
occasion. Important developmental changes in gene expres-
sion were found for this age period. Depending on the
different competing models that all fitted the data well,
between 19% and 40% of the total variation in HDL consisted
of the effects of newly expressed genes. Total heritability
estimates, including the effects of both time-stable and newly
expressed genes, were '80% and remained stable over the 3
measurement occasions.
Friedlander et al62 analyzed changes in total cholesterol,
LDL, HDL, and triglycerides over a 10-year time period
using data from 2 examinations of the Kaiser-Permanente
women twin study. Average ages at the 2 examinations were
41 and 51 years. Moderate heritability estimates of '30%
were demonstrated for changes in LDL and HDL cholesterol.
No significant genetic effect on change in total cholesterol or
triglycerides was found. The genetic influence on changes in
LDL and HDL indicates that new genes come to expression
over this 10-year time span.
Williams and Wijesiri63 studied the stability of genetic
influences during middle age. They analyzed longitudinal
data of male veteran twins on total cholesterol, LDL, HDL,
and triglycerides. Between 48 and 63 years of age, subjects
were measured 3 times. As evidenced by the large correla-
tions between genetic effects at successive examinations,
similar genetic effects on lipids appear to be present through-
out this segment of the life span.
As an alternative to a longitudinal study, Snieder et al46
measured total cholesterol, LDL, HDL, triglycerides, apoA1,
apoB, and Lp(a) in a group of 160 middle-aged parents and
their twin offspring and in a group of 203 middle-aged twin
pairs of the same age as the parents in the first project.
Combining the data of both projects enabled the estimation of
the extent to which measured lipid traits are influenced by
different genes in adolescence and adulthood and at the same
time allowed the estimation of heritabilities for each sex and
generation separately. Heritabilities were similar for both
sexes and both generations. Larger total variances in the
parental generation could be ascribed to proportional in-
creases in both unique environmental and additive genetic
variance from childhood to adulthood, which led to similar
heritability estimates in adolescent and middle-aged twins.
TABLE 2. Twin Studies Estimating Heritability (h 2) in Apolipoproteins and Lp(a), in Ascending Order According to Age
Investigator Pairs of Twins
Age, y
Sex Adjustment
h 2
Mean (SD) Range ApoA1 ApoB Lp(a)
Boomsma et al16,29 35 MZM, 35 MZF 16.7 (2.0) 13.0–22.0 Male 0.78 0.48 0.98*
31 DZM, 30 DZF, 29 DOS Female 0.78 0.48 0.93*
Sistonen and Ehnholm50 65 MZ, 70 DZ 36.0 (?) 20.0–69.0 Sex 0.36
Berg45,51 44 MZM, 54 MZF ? (?) 33.0–61.0 Male 0.53 0.52†
46 DZM, 54 DZF Female 0.53 0.74†
Snieder et al46 39 MZM, 50 MZF 44.1 (6.7) 34.0–63.0 Male 0.58 0.73 0.87
36 DZM, 40 DZF, 38 DOS Female 0.58 0.73 0.87
Austin et al52 338 MZF, 250 DZF 51.0 (?) ? 0.94
Kuusi et al53 17 MZM, 18 DZM 55.0 (?) 48.0–63.0 0.66
Hong et al54 63 MZ, 108 DZ 57.6 (5.3) 50.0–64.0 Age, sex 0.94
Heller et al35 57 MZ, 94 DZ ? (?) 52.0–65.0 Age, sex 0.69 0.78
Hayakawa et al55 42 MZM, 22 MZF ? (?) 50.0–74.0 Both 0.48 0.80
17 DZM, 2 DZF
Lamon-Fava et al34 109 MZM, 113 DZM 63.0 (?) 60.0–70.0 0.38 0.91 0.67
Env 0.38 0.85
Hong et al54 55 MZ, 78 DZ 71.1 (4.4) 65.0–86.0 Age, sex 0.94
Heller et al35 56 MZ, 95 DZ ? (?) 66.0–86.0 Age, sex 0.52 0.51
For explanation of abbreviations, see the footnote to Table 1.
*Estimates are the same for parents and their twin offspring (152 families; see Reference 16).
†Estimates for apoB are based on a smaller number of twin pairs, as listed in Table 1.
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Although the magnitudes of heritabilities were similar across
generations, results showed that for total cholesterol, triglyc-
erides, HDL, and LDL, partly different genes are expressed in
adolescence compared with adulthood. For triglycerides, only
46% of the genetic variance was common to both age groups;
for total cholesterol, this proportion was 80%. Intermediate
values were found for HDL (66%) and LDL (76%). The rest
of the genetic variance can thus be attributed to age-specific
genetic effects. For apoA1, apoB, and Lp(a), no age effects
were found, implying that the same genes act in both
generations.
Conclusions With Respect to Age Effects
Based on the reviewed cross-sectional and longitudinal twin
studies, it can now be concluded that the magnitude of the
genetic influence for total cholesterol, LDL, HDL, and
triglycerides remains relatively stable with age, with consis-
tently high heritability estimates. However, the limited num-
ber of available longitudinal studies point to the existence of
age-dependent gene expression in at least some of the lipids
and lipoproteins. New genes are expressed during adoles-
cence61 and during middle age in women,62 and gene expres-
sion is different in childhood and adulthood.46 These results
indicate that lipids and lipoproteins are influenced by a
different combination of multiple genes in different periods
of life.
For apolipoproteins and Lp(a), less information proved to
be available in the literature. Although heritability estimates
were, therefore, more variable for these traits also, no clear
age trend in the magnitude of heritability estimates could be
detected. The only study that investigated whether gene
expression was age dependent for these traits found no
evidence for such an effect.46 For Lp(a) this was an expected
finding, in accordance with evidence that .90% of the
variation in Lp(a) is determined by a single gene, the apo(a)
gene,48,49 which is located on the tip of the long arm of
chromosome 6.5,8 In their study of 5- to 13-month-old babies
and their parents, Wang et al11 concluded, on the basis of the
high parent-offspring correlations, that the apo(a) gene is
fully expressed before the age of 1 year. The difference in
age-specific genetic influence on lipids and lipoproteins
compared with the apolipoproteins might point to a simpler
genetic architecture for the apolipoproteins. In contrast to the
genetic architecture of cholesterol, triglycerides, LDL, and
HDL in which, besides some major gene effects, most genetic
variation is polygenic,64–67 genetic variation in apolipopro-
teins may be largely determined by 1 gene [as in Lp(a)] or a
few major genes whose effects remain stable with age.
Pleiotropy in Lipids and (Apo)lipoproteins
The majority of quantitative genetic studies of the lipid
system have used univariate analysis to decompose the
variation of single lipid variables into its constituent parts.
However, lipids, lipoproteins, and apolipoproteins compose a
complex system of highly intercorrelated traits68,69 that most
probably act in concert to cause an increased cardiovascular
risk. Therefore, it is important to acquire insight into the
sources of their covariation. Multivariate genetic modeling of
twin (or family) data not only involves a decomposition of
phenotypic variances into its various components but also
makes it possible to determine to what extent the covariation
between multiple measures is due to common genetic and/or
common environmental factors.70,71 Multivariate models can
thus be an important aid in unraveling the sources of
interrelations between multiple components of the lipid
system.
Only a few studies have performed quantitative genetic
analyses on multiple components of the lipid system simul-
taneously. Colletto et al72 used a bivariate path model to
analyze lipid data (cholesterol, triglycerides, VLDL, LDL,
and HDL) from 105 pairs of Brazilian twins of both sexes.
This approach enabled them to estimate the genetic correla-
tion between the genes for the different lipid components. For
all possible pairings, significant genetic correlations were
found with the highest values for total cholesterol and LDL
(0.76) and for triglycerides and VLDL (0.83). Genetic corre-
lations between HDL and both triglycerides and VLDL were
negative (20.24 and 20.26, respectively). On the basis of the
high genetic correlations for all lipid variables, the authors
suggested that there may be 1 common genetic factor for all
lipid components. Mosteller73 employed a triangular
(Cholesky) decomposition on data from 381 female twin
pairs, including body mass index, HDL, LDL, and age.
Dominance genetic effects were found to be most important
in bringing about the phenotypic correlation between HDL
and LDL (20.15). Heller et al69 employed multivariate model
fitting (a Cholesky decomposition) on data from younger
(,65 years) and older (.65 years) twins, reared apart and
together, to partition phenotypic correlations between total
serum cholesterol, triglycerides, HDL, apoA1, and apoB into
their genetic and environmental sources. Both genetic and
unique environmental factors were found to be important in
mediating the phenotypic correlation, but there was no
evidence for a single genetic factor common to all 5 lipids.
Using bivariate analysis on data from 100 MZ and 72 DZ
twin pairs, Knoblauch et al41 detected common genetic
influences on HDL and triglycerides and on LDL and
triglycerides, but not on HDL and LDL. Genetic correlations
were not reported.
All of the above studies point to the importance of common
genetic effects mediating intercorrelations between lipid
traits. However, the results of Heller et al69 suggest that the
underlying genetic architecture is not simple: there does not
seem to be 1 gene or set of genes responsible for the
covariance between the different lipid components. Several
family studies confirm the complexity of the genetic archi-
tecture of the lipid system. Vogler et al74 analyzed family data
on VLDL, LDL, and HDL within a multivariate path model.
Genetic correlations between HDL and VLDL (20.22) and
between VLDL and LDL (0.35) were found, but phenotypic
covariation of all 3 lipoproteins could not be ascribed to a
single genotype. Mahaney et al75 conducted multivariate
analysis on data from 569 subjects in 25 pedigrees and found
a significant genetic correlation (20.52) between HDL and
triglycerides, indicating pleiotropy. However, the authors
found no support for the so-called conjoint hypothesis, which
states that combined low HDL and high triglycerides are
inherited as a single phenotype. Instead, they concluded that
the inverse relation between the 2 traits throughout their
normal ranges of variation as well as at the extremes is
influenced by shared genes and shared environments. Factor
analysis of phenotypic, genetic, and environmental correla-
2830 Arterioscler Thromb Vasc Biol. December 1999
 at Vrije n December 23, 2010 atvb.ahajour als.orgDo nloaded from 
tion matrices of lipid data from the Tel Aviv–Heidelberg
3-generation offspring study identified a few distinct groups:
apoA1-dependent lipids (apoA1 and HDL fractions) and
apoB-dependent lipids (apoB, total cholesterol, and LDL).
Triglycerides and Lp(a) seemed to be relatively independent
of all other lipids.76
Although multivariate twin studies have yielded important
information on the genetic (and environmental) origin of
correlations within the lipid system, only exploratory quan-
titative genetic models like the triangular (Cholesky) decom-
position were applied. These models have limited explanatory
power because they do not allow tests of the direction of
causation between different phenotypes. Not all associations
need be explained in terms of common genetic or environ-
mental factors (see Reference 77 for a range of possible
bivariate models). Future studies, therefore, will have to
apply models that try to incorporate prior physiological
knowledge on the causal relationships between different
components of lipid metabolism.78 One example of such a
relation is the basic role that apolipoproteins play in the
metabolism of other lipoprotein particles like VLDL, LDL,
and HDL, by acting as a structural protein and a ligand for
cell-surface receptors.3
Implications for Gene Finding
Use of Twins in QTL Detection
High heritabilities of lipids and (apo)lipoproteins provide a
strong argument for further research with the ultimate goal to
locate the genes and subsequently uncover their function.
Identification of these genes and their function will increase
our insight into the regulation of levels and the variability of
lipids and (apo)lipoproteins, which may eventually enable the
development of interventions tailored to subjects with spe-
cific genetic predispositions.
Most lipid traits are continuously distributed and influ-
enced by multiple genes [with the notable exception of
Lp(a)], each with a relatively small effect. As the transmis-
sion of these complex polygenic traits does not follow simple
mendelian rules, identification of underlying genes (also
called QTLs) is difficult. Recent progress in molecular
genetics has enabled the production of a dense marker map of
the human genome, which has brought the localization of
QTLs within reach. Several methods have been developed to
map loci that influence quantitative traits in data from sibling
pairs.79,80 These methods suppose that if a marker is coseg-
regating with a quantitative trait, then siblings whose trait
values are more alike are more likely to receive the same
alleles identical by descent (IBD) at a closely linked marker
locus than are siblings whose resemblance for the trait is less.
Because DZ twins are genetically full siblings, all sib-pair
methodology can be applied equally well to DZ twin data. If
measurements of the phenotypes of interest (eg, lipids) are
available, all that is additionally needed are DNA marker
data. Using DZ twins instead of sib-pairs even has some
additional advantages. DZ twins are less likely to have
different fathers and, more important, DZ twin pairs are more
closely matched for age (or age-dependent gene expression)
and environmental influences (eg, cohort effects). This means
that differential resemblance among DZ twin pairs will
remain strictly a function of differential IBD sharing, whereas
differential sib-pair resemblance maybe confounded by envi-
ronmental and age effects.2
The extension of the classic twin study with DNA marker
data enables the search for previously unknown QTLs in a
genome scan. Alternatively, the effect of known candidate
genes may be tested for linkage with the phenotype within the
same twin study (See Reference 81 for a list of candidate
genes for lipid metabolism and their chromosomal positions).
Two recent studies applied the latter approach for lipid data.
Knoblauch et al41 examined linkage between markers close to
the LDL receptor gene, the lipoprotein lipase gene, and the
macrophage scavenger receptor gene and total cholesterol,
LDL, HDL and triglycerides in 72 DZ twin pairs. The data
suggested a significant influence of the macrophage scaven-
ger receptor gene on HDL and a weak effect on triglycerides.
No other linkages were found. Austin et al82 tested the effects
of 8 different candidate genes on LDL cholesterol, LDL
particle size, HDL, triglycerides, and apoB in 126 women
twin pairs. Results suggested linkage between markers for the
apoB gene and LDL particle size and plasma levels of HDL,
triglycerides, and apoB. A further linkage was found between
the gene for the microsomal triglyceride-transfer protein and
triglycerides.
Another generally more powerful method to investigate the
phenotypic effect of a specific locus in twin or sib-pair data
is to use tests for association, as opposed to linkage. Such
approaches need to take into account the dependency of the
observations within sib-pairs.83 However, these methods may
produce spurious results in the presence of population admix-
ture. Therefore, applications of the transmission disequilib-
rium test for use in sibship data are being developed.84,85
These transmission disequilibrium tests are insensitive to the
effects of population admixture and provide a test for both
linkage and association if sibships consist of 2 sibs only (ie,
sib-pairs).
Implications of Pleiotropy
Sib-pair strategies have several advantages compared with
other methods.86 Trait and genetic-marker data need be
obtained from siblings only, rather than from large multigen-
erational pedigrees. Furthermore, sib-pair methods do not
involve any assumptions concerning the mode of transmis-
sion, which implies that the intermediate step of segregation
analysis between twin/family studies and linkage analysis is
no longer necessary. However, 1 major drawback that sharply
contrasts with the aforementioned advantages of the sib-pair
method is that even with large numbers of highly poly-
morphic markers that enable determination of the IBD status
of siblings, the power to detect a single locus that influences
quantitative traits in humans remains low (eg, see References
87 and 88).
One strategy to increase the power to detect QTLs is to
make use of the pleiotropic influence of genes on multiple
lipid traits and to use multivariate genetic modelling.89 Ample
evidence shows that correlations between lipid traits are at
least partly due to common genetic factors. Multivariate
analysis can be used to test whether the same genetic factor,
or QTL, pleiotropically influences multiple phenotypically
correlated lipid traits. If a common genetic factor is found,
then scores on this factor can be constructed for an individual
by standard methods for the estimation of factor scores.90,91
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This approach to estimate an individual’s genotypic value at
a QTL reduces not only environmental variance but also the
background genetic variance not associated with the QTL. In
several simulation studies, Boomsma and colleagues92–94 and
Martin et al2 have shown that, with this application of
multivariate modeling, the power to detect QTLs in a sib-pair
analysis of quantitative traits can be increased substantially.
Once genes responsible for coaggregation between lipid
traits have been located and their physiological pathways
uncovered, this knowledge can be effectively applied in the
development of (pharmacological) therapies and the design of
intervention strategies. The most cost-effective use of re-
sources is to focus on intervention that will have the largest
impact on overall risk. Pharmacological intervention that
affects multiple risk factors will have a greater effect on
public health than do interventions focusing on a single risk
factor only.36
Implications of Age Dependency
Evidence of age-dependent gene expression also has impor-
tant implications for the design of gene-finding studies.
Because genes influencing a lipid trait at 1 age period may be
different from genes expressed during another age period,
selection of homogeneous age samples will optimize the
power to detect those genes. Obviously, selection of such a
homogeneous age sample is easier in sib- and DZ twin–pair
designs than in family studies.
Alternatively, twin or sib-pair studies can be optimally
used to gain a better understanding of several types of
age-dependent gene expression. First, gene regulation of lipid
changes during a specific phase in development can be
investigated. Twins or sib-pairs can be followed up longitu-
dinally through a specific age period like puberty or the
menopause, when gene expression is most likely to change,
with the aim of pinpointing the specific loci involved in
developmental changes in gene expression. Second, age-
dependent changes in the penetrance of underlying “level”
genes can be examined. Possibly triggered by the cumulative
exposure to certain environmental factors, specific genes may
be switched on, leading to a gradual change in lipid values
with age. Jarvik et al,95 for example, found that changes with
age over a 16-year period (48 to 64 years of age) in total
cholesterol and triglycerides were dependent on the specific
apoE genotype. Finally, an effort can be made to map
so-called “variability” genes. These genes are sensitive to
environmental changes that cause large intraindividual vari-
ability in lipid traits, which per se may comprise a risk factor
for coronary heart disease.62 Magnus et al96 and Martin et al97
found that intrapair variance of cholesterol in MZ pairs
(which must be solely due to environmental factors) who had
blood group M2 (ie, blood group N) was greater than in pairs
who had M1 (ie, blood groups M and MN), suggesting a
higher environmental sensitivity of the M2 genotype. This
concept was confirmed in a low-fat dietary intervention
study, which showed that individuals with blood group N had
the greatest lowering in their cholesterol values, whereas the
heterozygous group (MN) showed the least change.98 Finding
environmentally sensitive genes may thus have important
practical implications in enabling the targeting of treatment to
the most responsive individuals. MZ twin studies could be
especially useful in finding these environmentally sensitive
genes.99
Conclusions
Twin studies are and have been very useful in dissecting the
genetic architecture of lipids, lipoproteins, and apolipopro-
teins. Even in the absence of genotypic data, they have
provided a wealth of information on the importance of
genetic factors in determining lipid traits, the age-dependent
expression of these genetic factors, and their pleiotropic
effect on multiple lipid traits. Rapid developments in molec-
ular genetics and biometrics have brought in a new era in
which the detection of QTLs that underlie complex lipid traits
has come within reach. Twin studies will continue to play an
important role in this new era. Taking account of pleiotropy
and age-dependent gene expression in study design and data
analysis will improve the power and efficiency to find QTLs
for components of the lipid system.
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